The Indian Journal of Pediatrics

, Volume 69, Issue 2, pp 155–168

Upper gastrointestinal bleeding: Etiology and management

  • N K Arora
  • S. Ganguly
  • P. Mathur
  • A. Ahuja
  • A. Patwari
Symposium on Hepatology-II

Abstract

Upper gastrointestinal bleeding is a potentially fatal condition at times due to loss of large volumes of blood. Common sources of upper gastrointestinal bleeding in children include mucosal lesions and variceal hemorrhage (most commonly extra hepatic portal venous obstruction) and, in intensive care settings infections and drugs are other etiological factors associated with bleeding. Massive upper Gl bleeding is life threatening and requires immediate resuscitation measures in the form of protection of the airways, oxygen administration, immediate volume replacement with ringer lactate or normal saline, transfusion of whole blood or packed cells and also monitoring the adequacy of volume replacement by central venous lines and urine output. Upper Gl endoscopy is an effective initial diagnostic modality to localize the site and cause of bleeding in almost 85–90% of patients. Antacids supplemented by H2-receptor antagonists, proton pump inhibitors and sucralfate are the mainstay in the treatment of bleeding from mucosal lesion. For variceal bleeds, emergency endoscopy is the treatment of choice after initial haemodynamic stabilization of patient. If facilities for endoscopic sclerotherapy (EST) are not available, pharmacotherapy which decreases the portal pressure is almost equally effective and should be resorted to. Shunt surgery is reserved for patients who do not respond to the above therapy. β blockers combined with sclerotherapy have been shown to be the most effective therapy in significantly reducing the risk of recurrent rebleeding from varices as well as the death rates, as compared to any other modality of treatment. Based on studies among adult patients, presence of shock, co-morbidities, underlying diagnosis, presence of stigmata of recent hemorrhage on endoscopy and rebleeding are independent risk factors for mortality due to upper Gl bleeding. Rebleeding is more likely to occur if the patient has hematemesis, liver disease, coagulopathy, hypotension and or anemia. There is a great need for conducting therapeutic trials as well as identifying predictors of outcome of upper Gl bleeding in children to develop evidence based management protocols.

Key words

Acute upper Gl bleed Etiology Management Portal hypertension 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Yachha SK, Khanduri A, Sharma BC, Kumar M. Gastrointestinal bleeding in children.J Gastroenterol Hepat 1996; 11: 903–907.Google Scholar
  2. 2.
    Oslon AD, Hillemeier AC. Gastrointestinal hemorrhage. In Walker WA, ed.Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management. St. Louis, Mosby 1996, 251–270.Google Scholar
  3. 3.
    Mittal SK, Kalra KK, Agarwal V. Diagnostic upper GI endoscopy for hemetemesis in children. Experience from a pediatric gastroenterology center in North India.Indian J Pediatr 1994; 61: 651–654.PubMedCrossRefGoogle Scholar
  4. 4.
    Cox K, Ament ME. Upper gastrointestinal bleeding in children and adolescents.Pediatrics 1979; 63 (3): 408–413.PubMedGoogle Scholar
  5. 5.
    Fleischer D. Etiology and prevalence of severe persistent upper gastrointestinal bleeding.Gastroenterology 1983; 84: 538–543.PubMedGoogle Scholar
  6. 6.
    Gostout CJ, Kenneth KW, Ahlquist DAet al. Acute gastrointestinal bleeding. Experience of a specialized management team.J Clin Gastroenterol 1992; 14(3): 260–267.PubMedCrossRefGoogle Scholar
  7. 7.
    Lacorix J, Nadeau D, Lakerge S, Gauthier M, Lapierre G, Farrel CA. Frequency of upper gastrointestinal bleeding in a pediatric intensive care unit.Crit Core Med 1992; 20: 35–42.CrossRefGoogle Scholar
  8. 8.
    Gormally S. Gastritis and Peptic Ulcer Disease. In Walker WA ed.Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management. St. Louis, Mosby 1996; 506–527.Google Scholar
  9. 9.
    Drumm B, Rhoads JM, Stringer DAet al. Peptic ulcer disease in children: Etiology, clinical findings and clinical course.Pediatrics 1988; 82 : 410–414.PubMedGoogle Scholar
  10. 10.
    Drumm B, Perez-Perez GI, Blaser MJ, Sherman PM. Intra familial clustering in helicobacter pylori infection.N Engl J Med 1990; 322 (6): 359–363.PubMedCrossRefGoogle Scholar
  11. 11.
    Yeung CKet al. Helicobacter pylori and associated duodenal ulcer.Ardi Dis Child 1990; 65: 1212–1216.Google Scholar
  12. 12.
    Labenz J, Peitz U, Kohl H, Kaiser J, Malfertheiner P, Hackersbergeret al. Helicobacter pylori increases the risk of peptic ulcer bleeding: a casecontrol study.Ital J Gastroenterol Hepatol 1999; 31(2): 110–115.PubMedGoogle Scholar
  13. 13.
    Chan FK, Chung SC, Suen BY, Lee YT, Leung WK, Leung VKet al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking lowdose aspirin or naproxen.N Engl J Med 2001; 344 (13): 967–973.PubMedCrossRefGoogle Scholar
  14. 14.
    Katelaris PH, Tippet GH, Norbu P, Lowe DG, Brennan R, Farming MJ. Dyspepsia, helicobacter pylori and peptic ulcer in a randomly selected population in India.Gut 1992; 33: 1462–1466.PubMedCrossRefGoogle Scholar
  15. 15.
    Gill HH, Majumdar P, Shankaran K, Desai HG. Age related prevalence of helicobacter pylori antibodies in Indian subjects.Indian J Gastroenter 1994; 13(3): 92–94.Google Scholar
  16. 16.
    Roduquez LAG, Herschel J. Risk of upper gastrointestinal bleeding and perforation associated with individual non steroidal anti inflammatory drugs.Lancet 1994; 343: 769–772.CrossRefGoogle Scholar
  17. 17.
    Iichtehberger LMet al. Effect of 16 — dimethyl prostaglandin E2 on the surface hydrophobicity of aspirin treated canine gastric mucosa.Gastroenterology 1985; 88: 308–314.Google Scholar
  18. 18.
    Fromm D. How do non steroidal anti inflammatory drugs affect gastric mucosal defences ?Clin Invest Med 1987; 10: 251–258.PubMedGoogle Scholar
  19. 19.
    Messer JMet al. Association of adreno corticosteroid therapy and peptic ulcer disease.N Engl J Med 1983; 309: 21–24.PubMedCrossRefGoogle Scholar
  20. 20.
    Prandi D, Rueff B, Roche-Sicot Jet al. Life threatening hemorrhage of the digestive tract in cirrhotic patients.Am J Surg 1976; 131: 204–209.PubMedCrossRefGoogle Scholar
  21. 21.
    Arora NK, Lodha R, Arora N. Portal hypertension. In Suraj Gupte, ed.Recent Advances in Pediatr 1998 : 317-348.Google Scholar
  22. 22.
    Alvarez F, Bernard O, Brunelle Fet al. Portal hypertension in children: Clinical investigatons and hemorrhage risk.J Pediatr 1983; 103: 696–702.PubMedCrossRefGoogle Scholar
  23. 23.
    Arora NK, Lodha R, Gulati S, Gupta AK, Mathur P, Joshi Medha S. Portal Hypertension in North Indian Children.Indian J Pediatr 1998; 65: 585–591.PubMedCrossRefGoogle Scholar
  24. 24.
    Rector WG, Reynolds TB. Risk factors for hemorrhage from esophageal varices and acute gastric erosions.Clin Gastroenterol 1985; 14: 139–153.PubMedGoogle Scholar
  25. 25.
    Sarin SK, Sundaram KR, Ahuja RK. Predictors of variceal bleeding.Gut 1989; 30: 1757–1764.PubMedCrossRefGoogle Scholar
  26. 26.
    Prolla J, Diehl AS, Benvenuti GAet al. Upper gastrointestinal fiberoptic endoscopy in pediatric patients.Gastrointest Endosc 1983; 29: 279–281.PubMedGoogle Scholar
  27. 27.
    Leincke J, Schaffer R, Hogan W. Emergency endoscopy in acute upper GI bleeding(UGB): does timing affect the significance of diagnostic yield?Gastrointest Endosc 1976; 22: 32–38.Google Scholar
  28. 28.
    Boyan C. Cold or warm blooded for massive transfusion.Am Surg 1964; 160–182.Google Scholar
  29. 29.
    Katon R. Complications of upper gastrointestinal endoscopy in the gastrointestinal bleeder.Dig Dis Sd 1981; 26: 475–545.Google Scholar
  30. 30.
    Hoare AM. Comparative study between endoscopy and radiology in acute upper gastrointestinal hemorrhage.Br Med J 1975; 1: 27.PubMedGoogle Scholar
  31. 31.
    Driscoll D. The role of radionudide imaging in the diagnosis of gastrointestinal bleeding in children.Radiography 1986; 52: 237–239.PubMedGoogle Scholar
  32. 32.
    Afshani E, Bergee P. Gastrointestinal tract angiography in infants & children.J Pediatr Gastroenterol Nutr 1986; 5: 173–186.PubMedGoogle Scholar
  33. 33.
    Alavi A, Ringh E. Localisation of gastrointestinal bleeding: superiority of 99mTc sulfur colloid compared with angiography.Am J Roent 1981; 137: 741–748.Google Scholar
  34. 34.
    Keller F, Rosch J. Value of angiography in diagnosis and therapy of acute upper gastrointestinal hemmorrhage.Dig Dis Sd 1981; 26: 785–895.Google Scholar
  35. 35.
    Meyerontz M, Fellows K. Angiography in gastrointestinal bleed in children.Am J Roentgenol 1984; 143: 837–840.Google Scholar
  36. 36.
    Levine RS, Steinberg WM. Antacids: in Gastrointestinal Pharamacotherapy. WB Saunders & Co. Philadelphia. 1st edn. 1993.Google Scholar
  37. 37.
    Zeldir JB, Friedman LS, Isselbacher KJ. Ranitidine: A new H2 receptor antagonist.N Eng J Med 1983; 309: 1368.CrossRefGoogle Scholar
  38. 38.
    Clissold SP, Campoli-Richard DM. Omeprazole-A prelimnary review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.Drugs 1986; 32: 15–47.PubMedCrossRefGoogle Scholar
  39. 39.
    Nasgashima R. Mechanism of action of sucralfate.J Clin Gastroenterol 1981; 3 (suppl 2): 117.Google Scholar
  40. 40.
    D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: A meta analytic review.Hepatology 1995; 22(1): 332–354.PubMedCrossRefGoogle Scholar
  41. 41.
    Boles ET. Portal hypertension. In, Holder TM, Ashoraft WF, eds.Pediatric Surgery WB Saunders, London, 1980; 534.Google Scholar
  42. 42.
    Westaby D, Melia WM, MacDougal BRet al. Injection sclerotherapy for esophageal varices. A prospective randomized controlled trial of different treatment schedules.Gut 1984; 25: 129–132.PubMedCrossRefGoogle Scholar
  43. 43.
    Baillie J, Yudelman P. Complications of endoscopic sclerotherapy of esophageal varices.Endoscopy 1992; 24: 284–291.PubMedCrossRefGoogle Scholar
  44. 44.
    Hill ID, Bowie ND. Endoscopic sclerotherapy for control of bleeding varices in children.Am J Gastroenterol 1991; 86 (4): 472–476.PubMedGoogle Scholar
  45. 45.
    Sasaki T, Hasegawa T, Nakajima K, Tanano H, Wasa M, Fukui Yet al. Endoscopic variceal ligation in the management of gastroesophageal varices in the post-operative biliary atresia.J Ped Surg 1998; 33(11): 1628–1632.CrossRefGoogle Scholar
  46. 46.
    Fleischer D. Endoscopic therapy of upper gastrointestinal bleeding in humans.Gastroenterol 1986; 90: 217–234.Google Scholar
  47. 47.
    Papp JP. Endoscopic electro coagulation in the management of upper gastrointestinal bleeding.Surg Clin of North Am 1982; 62: 797–806.Google Scholar
  48. 48.
    Sharara Al, Rockey DC. Gastresophageal variceal hemmorhage.N Engl J Med 2001; 345(9): 669–681.PubMedCrossRefGoogle Scholar
  49. 49.
    Haddock G, Garden OJ, MeKee RFet al. Esophageal tamponade in the management of acute variceal hemorrhage.Dig Dis Sci 1989; 34: 913–918.PubMedCrossRefGoogle Scholar
  50. 50.
    Evans S, Stovroff M, Heiss K, Ricketts R. Selective distal splenorenal shunts for intractable variceal bleeding in pediatric portal hypertension.J Pediatr Surg 1995; 30(8): 1115–1118.PubMedCrossRefGoogle Scholar
  51. 51.
    Shah R, Nagral SS, Mathur SK. Results of a modified Sugiura’s devascularisation in the management of ‘unshuntable’ portal hypertension.HPB Surg 1999; 11: 235–239.PubMedCrossRefGoogle Scholar
  52. 52.
    Prasad AS, Subhash G, Vivek K, Pande GK, Shani P, Nundy S. Proximal splenorenal shunts for Extrahepatic portal Venous obstruction in children.Ann Surg 1994; 219(2): 193–196.PubMedCrossRefGoogle Scholar
  53. 53.
    Goncalves ME, Cardosos SR, Maksoud JG. Prophylactic sclerotherapy in children with esophageal varices: Long term results of a controlled prospective randomized controlled trial.J Pediatr Surg 2000; 35: 401–405.PubMedCrossRefGoogle Scholar
  54. 54.
    Hayes PC, Davis JM, Lewis JA, Bouchier IAD. Meta — analysis of the value to propranolol in prevention of variceal hemorrhage.Lancet 1990; 336: 153–156.PubMedCrossRefGoogle Scholar
  55. 55.
    Rockall TA, Logan RFA, Devlin HB, Northfield TC. Variation in outcome after acute upper gastrointestinal hemorrhage. The National Audit of Acute Upper Gastrointestinal Haemorrhage.Lancet 1995; 346: 346–349.PubMedCrossRefGoogle Scholar
  56. 56.
    Rockall TA, Logan RFA, Devlin HB, Northfield TC. Risk assessment after upper gastrointestinal hemorrhage.Gut 1996; 38: 316–321.PubMedCrossRefGoogle Scholar
  57. 57.
    Terdimann JP, Ostroff JW. Risk of persistent or recurrent and intractable upper gastrointestinal bleeding in the era of therapeutic endoscopy.Am J Gastroenterol 1997; 92(10): 1805–1811.Google Scholar
  58. 58.
    Corley DA, Stefan AM, Michael W, Cook EF, Lee TH. Early indicators of prognosis in upper gastrointestinal hemorrhage.Am J Gastroenterol 1997; 93(3): 336–340.CrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2002

Authors and Affiliations

  • N K Arora
    • 1
  • S. Ganguly
    • 1
  • P. Mathur
    • 1
  • A. Ahuja
    • 1
  • A. Patwari
    • 1
  1. 1.Division of Pediatric Gastroenterology, Hepatology & Nutrition, Department of PediatricsAll India Institute of Medical SciencesNew DelhiIndia

Personalised recommendations